TrialThe oncologist2015

Ramosetron Versus Ondansetron in Combination With Aprepitant and Dexamethasone for the Prevention of Highly Emetogenic Chemotherapy-Induced Nausea and Vomiting: A Multicenter, Randomized Phase III Trial, KCSG PC10-21.

Hyo Jung Kim et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.